Susquehanna International Group, LLP Jasper Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$1.19 - $1.79 $11,305 - $17,005	-9,500 Reduced 13.19%	62,500 $85,000
Q1 2023 May 16, 2023	BUY	$1.48 - $2.74 $106,560 - $197,280	72,000 New	72,000 $130,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.86 $295,657 - $659,674	-170,900 Reduced 87.33%	24,800 $48,000
Q1 2022 May 16, 2022	SELL	$2.96 - $8.01 $108,632 - $293,967	-36,700 Reduced 15.79%	195,700 $695,000
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $1.68 Million - $3.82 Million	232,400 New	232,400 $1.82 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $821M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.